Integra LifeSciences IART Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's common stock, shares authorized (in shares)?
- Integra LifeSciences (IART) reported common stock, shares authorized (in shares) of $240M in Q1 2026.
- How has Integra LifeSciences's common stock, shares authorized (in shares) changed year-over-year?
- Integra LifeSciences's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $240M to $240M.
- What is the long-term trend for Integra LifeSciences's common stock, shares authorized (in shares)?
- Over 5 years (2020 to 2025), Integra LifeSciences's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $240M to $240M.